Investors in Health Diagnostics

Displaying 1-10 out of 2004

SOSV

SOSV is a venture capital firm headquartered in New Jersey, focused on seed-to-growth stage investments in sectors such as biotechnology, hardware, robotics, and cross-border software, particularly in Asia. Established in 1995, SOSV operates several global accelerator programs, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet, Food-X for disruptive food technologies, and dlab for blockchain innovations. The firm invests in approximately 150 companies annually and emphasizes a strategy that combines early-stage funding with extensive support, facilitating product development, customer acquisition, and scaling. SOSV's commitment to nurturing revolutionary deep technologies and its proven track record position it among the top 10% of venture capital funds worldwide.
Made 128 investments in Health Diagnostics

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that promotes the development and adoption of new technologies in the region. Over the past 30 years, it has emerged as a prominent provider of seed stage capital, investing more than $170 million in over 1,750 technology companies, many of which have achieved significant industry success. In addition to financial support, Ben Franklin fosters university and industry collaborations to expedite the commercialization of scientific innovations. The organization is dedicated to enhancing the regional entrepreneurial ecosystem, creating jobs, and transforming lives through its initiatives.
Made 23 investments in Health Diagnostics

5Y Capital

5Y Capital, previously known as Morningside Venture Capital, is a private equity and venture capital firm based in Shanghai, China, with additional offices in Beijing and Hong Kong. Founded in 1992, it specializes in early-stage investments across a wide range of sectors, including healthcare, technology, fintech, consumer services, media, and education. The firm manages approximately USD 3 billion in funds, leveraging investments from prominent sovereign wealth funds, family offices, and other institutional investors. With an initial investment threshold of over USD 500,000 per portfolio company, 5Y Capital focuses primarily on opportunities in China and other emerging markets in Asia and the Pacific. It is a subsidiary of the Morningside Group, which has a long-standing commitment to socially responsible investing and philanthropic initiatives, particularly in education and scientific research.
Made 32 investments in Health Diagnostics

Rockstart

Rockstart is an accelerator and venture capital firm founded in 2011 and headquartered in Amsterdam, Netherlands, with additional offices in Copenhagen, Denmark, and Bogotá, Colombia. The firm specializes in supporting early-stage startups across four primary sectors: Energy, Health, AgriFood, and Emerging Technologies. Rockstart offers intensive programs that provide startups with access to capital, office space, and a network of mentors, partners, and investors. Its initiatives include customized programs that foster collaboration between startups and established companies, driving opportunities for co-creation and investment. Since its inception, Rockstart has invested in over 230 startups, helping them raise more than €90 million and create over 700 jobs. The firm emphasizes a structured six-month program that includes workshops on various business topics, culminating in a Demo Day where entrepreneurs present their ventures to potential investors and partners. Additionally, Rockstart has developed specialized programs such as Rockstart AI and Rockstart Impact Nepal to cater to specific markets and entrepreneurial needs.
Made 21 investments in Health Diagnostics

Insight Capital

Insight Partners is a global private equity and venture capital firm established in 1995, specializing in growth-stage investments in software, internet, and data services companies. With over $20 billion in assets under management, the firm has invested in more than 300 companies worldwide. Insight Partners emphasizes a hands-on approach to collaboration, leveraging the expertise of its team to foster significant growth and success for its portfolio companies. The firm promotes a culture that views growth as a pathway to opportunity, positioning itself as a trusted partner in the software industry.
Made 18 investments in Health Diagnostics

Khosla Ventures

Khosla Ventures is a venture capital firm founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems, and is headquartered in Menlo Park, California. The firm provides venture assistance and strategic advice to entrepreneurs focused on breakthrough technologies, managing over five billion dollars in assets. Khosla Ventures primarily targets investments in technology companies across various sectors, including consumer, enterprise, education, advertising, financial services, semiconductors, health, big data, agriculture, sustainable energy, and robotics. The firm engages in both seed funding for innovative projects and traditional venture investments, with funding amounts ranging from $100,000 to over $20 million. Khosla Ventures is known for taking significant risks, often being the sole investor in unconventional areas, while also collaborating with other firms for co-investment opportunities.
Made 61 investments in Health Diagnostics

Startup Health

StartUp Health is dedicated to improving global health and wellbeing through a long-term mission that spans 30 years. Established in 2011, the organization focuses on empowering a network of entrepreneurs, known as Health Transformers, to address significant health challenges termed "health moonshots." These moonshots encompass a range of critical areas, including access to care, cost reduction, disease cures, cancer eradication, women's and children's health, nutrition and fitness, brain health, mental well-being, addiction, longevity, and pandemic response. With a portfolio that includes over 330 companies across six continents and 26 countries, StartUp Health claims the largest health innovation portfolio worldwide. The initiative is supported by prominent investors and health organizations, highlighting its commitment to fostering innovation in the healthcare sector.
Made 65 investments in Health Diagnostics

ArchiMed

ArchiMed is an independent private equity firm founded in 2014, with a focus on investing in small to mid-sized European healthcare companies. Based in Lyon, France, the firm specializes in buyouts and growth capital for businesses in sectors such as care and wellness, medtech, biopharma, and public health. ArchiMed typically invests between €5 million and €15 million per transaction, but can go up to €50 million or higher, alone or with co-investors. The firm targets companies with revenues ranging from €5 million to €100 million, taking both minority and majority stakes. With an additional office in Paris, France, ArchiMed's investments are aimed at driving innovation and growth in the healthcare industry across Western Europe, including regions like France, the United Kingdom, and Switzerland.
Made 14 investments in Health Diagnostics

Techstars

Techstars is a global startup accelerator founded in 2006, headquartered in Boulder, Colorado. It provides a supportive environment for entrepreneurs through various programs, including mentorship-driven accelerators, startup programs, and corporate innovation partnerships. Techstars connects founders with a vast network of mentors, investors, and industry experts to foster company growth. The organization operates multiple accelerator programs worldwide, focusing on diverse sectors such as mobility, retail, and social impact. It also manages a venture capital fund that invests in innovative technology companies at early stages. With over 1,000 companies in its accelerator portfolio, Techstars has developed a reputation for nurturing successful startups across various markets, helping them scale and achieve significant valuations.
Made 61 investments in Health Diagnostics

New Alliance

New Alliance is a private equity and venture capital firm established in 2008, with headquarters in Shanghai, China. The firm focuses on early, growth-stage, and pre-IPO investments across various sectors, including high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services. New Alliance typically invests between $4.71 million and $31.41 million in its portfolio companies, aiming to support their development and expansion in competitive markets.
Made 12 investments in Health Diagnostics